Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-25

FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for risperidone by Westminster Pharmaceuticals, LLC to support a generic version of risperidone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)